X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (59) 59
female (48) 48
male (46) 46
index medicus (40) 40
cardiac & cardiovascular systems (36) 36
aged (29) 29
middle aged (27) 27
prognosis (25) 25
adult (23) 23
heart failure (20) 20
cardiovascular (16) 16
mortality (16) 16
disease (15) 15
analysis (14) 14
biomarkers - blood (14) 14
prospective studies (14) 14
follow-up studies (11) 11
risk factors (11) 11
heart failure - blood (10) 10
natriuretic peptide, brain - blood (10) 10
studies (10) 10
cancer (9) 9
echocardiography (9) 9
patients (9) 9
aged, 80 and over (8) 8
cardiac patients (8) 8
diagnosis (8) 8
natriuretic peptides (8) 8
quality of life (8) 8
retrospective studies (8) 8
health aspects (7) 7
portugal - epidemiology (7) 7
prevalence (7) 7
research (7) 7
treatment outcome (7) 7
association (6) 6
care and treatment (6) 6
heart (6) 6
heart failure - mortality (6) 6
medicine (6) 6
oncology (6) 6
predictive value of tests (6) 6
survival (6) 6
ventricular dysfunction, left - diagnostic imaging (6) 6
acute myocardial-infarction (5) 5
aortic valve stenosis - surgery (5) 5
atherosclerosis (5) 5
c-reactive protein (5) 5
cardiomyopathy (5) 5
cardiovascular disease (5) 5
cardiovascular-disease (5) 5
genetics (5) 5
health (5) 5
hiv infections - complications (5) 5
hypertension (5) 5
inflammation (5) 5
microbiology (5) 5
nt-probnp (5) 5
portugal (5) 5
severity of illness index (5) 5
ventricular dysfunction, left - etiology (5) 5
aids (4) 4
aortic stenosis (4) 4
aortic valve replacement (4) 4
bnp (4) 4
brain natriuretic peptide (4) 4
cohort studies (4) 4
comorbidity (4) 4
disease progression (4) 4
europe (4) 4
gastroenterology & hepatology (4) 4
heart failure - diagnosis (4) 4
heart failure - physiopathology (4) 4
heart-failure (4) 4
hiv infection (4) 4
hospitalization - statistics & numerical data (4) 4
impact (4) 4
medicine, general & internal (4) 4
mutation (4) 4
peptide fragments - blood (4) 4
pharmacology & pharmacy (4) 4
proportional hazards models (4) 4
risk (4) 4
science (4) 4
abridged index medicus (3) 3
age factors (3) 3
animals (3) 3
aortic valve - surgery (3) 3
aortic valve stenosis - diagnostic imaging (3) 3
atrophic gastritis (3) 3
biochemistry (3) 3
biomarkers (3) 3
body mass index (3) 3
c-reactive protein - metabolism (3) 3
cachexia (3) 3
cardiac abnormalities (3) 3
cardiology and cardiovascular medicine (3) 3
child (3) 3
cholesterol (3) 3
chronic disease (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 114, Issue 11, pp. 1663 - 1669
Journal Article
European Journal of Cancer Care, ISSN 0961-5423, 07/2019, Volume 28, Issue 4, pp. e13026 - n/a
Objective We provide a real‐world overview of multiple myeloma (MM) treatment patterns, outcomes and healthcare resource use (HRU) in Portugal. Methods Data... 
multiple myeloma | survival analysis | cancer treatment protocol | healthcare costs | healthcare utilisation | observational study | SURVIVAL | ONCOLOGY | NURSING | HEALTH CARE SCIENCES & SERVICES | REHABILITATION | OUTCOMES | Glycine - analogs & derivatives | Glycine - therapeutic use | Glycine - economics | Age Factors | Bortezomib - economics | Multiple Myeloma - economics | Humans | Middle Aged | Stem Cell Transplantation - economics | Male | Antineoplastic Agents - therapeutic use | Practice Patterns, Physicians | Immunologic Factors - economics | Lenalidomide - economics | Portugal | Proteasome Inhibitors - economics | Multiple Myeloma - therapy | Drug Costs - statistics & numerical data | Female | Stem Cell Transplantation - statistics & numerical data | Health Resources - economics | Survival Rate | Antineoplastic Agents - economics | Proteasome Inhibitors - therapeutic use | Thalidomide - economics | Boron Compounds - economics | Health Care Costs | Bortezomib - therapeutic use | Lenalidomide - therapeutic use | Progression-Free Survival | Aged | Thalidomide - therapeutic use | Boron Compounds - therapeutic use | Hospitalization - economics | Immunologic Factors - therapeutic use | Transplantation | Analysis | Multiple myeloma | Stem cells | Medical care, Cost of | Heterogeneity | Divergence | Immunomodulation | Transplants | Survival | Proteasome inhibitors
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 49, Issue 5, pp. 554 - 561
Journal Article
ecancermedicalscience, ISSN 1754-6605, 08/2019, Volume 13
Patients with skin cancer should be treated in healthcare units that ensure holistic and multidisciplinary approaches. Current healthcare units, especially... 
Mutation | Kinases | Immunotherapy | Skin cancer
Journal Article
Helicobacter, ISSN 1083-4389, 10/2013, Volume 18, Issue 5, pp. 325 - 337
Journal Article
Acta Medica Portuguesa, ISSN 0870-399X, 03/2019, Volume 32, Issue 3, pp. 202 - 207
Introduction: High values of lipoprotein(a), related to atherosclerosis progression, are often considered a marker of thrombosis. We assessed the... 
Lipoprotein(a) | Primary prevention | Cardiovascular diseases | Portugal | Atherosclerosis | MEDICINE, GENERAL & INTERNAL | Cardiovascular Diseases | Primary Prevention | MANAGEMENT | GUIDELINES | DISEASE | PREVENTION | STATINS | LP(A)
Journal Article
ecancermedicalscience, ISSN 1754-6605, 09/2017, Volume 11, p. 765
Cancer is the second most common cause of death in Portugal, with 24.3% of these deaths caused by malignant neoplasms. The strong impact on lost productivity... 
Economics | Costs | Health technology assessment | Health | Cancer | Productivity | Chemotherapy | Hospitals | Cost estimates | Disease | Initial public offerings | Oncology | Expenditures | Radiation therapy | Patients | Cancer therapies
Journal Article
Journal of Business Research, ISSN 0148-2963, 11/2016, Volume 69, Issue 11, pp. 5507 - 5511
The specific aim of this study is to identify the performance features of cancer centers in the European Union by using a fuzzy-set qualitative comparative... 
Comparative qualitative analysis | Financial performance | Cancer centers | QUALITATIVE COMPARATIVE-ANALYSIS | POLICY | BENCHMARKING | BUSINESS | HEALTH-CARE | EFFICIENCY | QCA | Analysis | Cancer
Journal Article
ecancermedicalscience, ISSN 1754-6605, 10/2016, Volume 10, p. 685
In modern health care systems, the soaring prices of drugs pose at least three major challenges: the growing economic burden of diseases, the uncertainty... 
Health care costs | Quality-adjusted life years | Health technology assessment | Outcomes measures | Economic evaluation | Cancer | Health care expenditures | Decision making | Technological change | Conflicts of interest | Objectives | Patients | Benefit cost analysis | Clinical outcomes | Cost control | Quality of life
Journal Article
CARDIOLOGY RESEARCH AND PRACTICE, ISSN 2090-8016, 2019, Volume 2019, pp. 2743650 - 9
Background. Sudden cardiac death (SCD) risk stratification in dilated cardiomyopathy (DCM) has been based on left ventricular ejection fraction (LVEF), even... 
CARDIAC & CARDIOVASCULAR SYSTEMS | Heart | Analysis | Genetic screening | Cardiomyopathy, Dilated
Journal Article
Revista Portuguesa de Cardiologia (English Edition), ISSN 2174-2049, 07/2019, Volume 38, Issue 7, pp. 485 - 493
Lipoprotein(a) [Lp(a)] is an independent cardiovascular risk factor but is closely associated with other similar risk factors that are manageable with... 
Lipoprotein(a) | Terapêutica farmacológica combinada | Doenças cardiovasculares | Risco cardiovascular | Atherosclerosis | Cardiovascular risk | Peripheral arterial disease | Doença arterial periférica | Cardiovascular disease | Aterosclerose | Lipoproteína(a) | Drug therapy, combination
Journal Article
BMJ Open, ISSN 2044-6055, 2012, Volume 2, Issue 4, p. e000595
ObjectivesBeing one of the main causes of morbidity and mortality in developed countries, ischaemic heart disease's (IHD) incidence and mortality present clear... 
MORTALITY | STROKE | MEDICINE, GENERAL & INTERNAL | POPULATIONS |